Literature DB >> 26097239

Brief report: association of CCR1, KLRC4, IL12A-AS1, STAT4, and ERAP1 With Behçet's disease in Iranians.

Inês Sousa1, Farhad Shahram2, David Francisco1, Fereydoun Davatchi2, Bahar Sadeghi Abdollahi2, Fahmida Ghaderibarmi2, Abdolhadi Nadji2, Niloofar Mojarad Shafiee2, Joana M Xavier1, Sofia A Oliveira1.   

Abstract

OBJECTIVE: To independently replicate the top findings from 4 published genome-wide association studies (GWAS) of susceptibility genes in Behçet's disease (BD).
METHODS: We tested 14 single-nucleotide polymorphisms (SNPs) in 13 genomic loci (excluding the major histocompatibility complex [MHC], IL10, and IL23R-IL12RB2, which have already been associated with BD in Iranians) for allelic and genotypic associations with BD in 973 patients and 828 controls from Iran and performed meta-analyses of the significantly associated markers.
RESULTS: Six SNPs (in decreasing order of significance, rs7616215 located 38 kb downstream of CCR1, rs2617170 [p.Asn104Ser] in KLRC4, rs17810546 in IL12A-AS1, rs7574070 in STAT4, and rs10050860 [p.Asp575Asn] and rs13154629 in ERAP1) were nominally associated with BD in both allelic association tests (5.05 × 10(-9) ≤ Pallele ≤ 7.55 × 10(-3) ) and sex-adjusted genotypic association tests (6.01 × 10(-9) ≤ adjusted P value ≤ 1.30 × 10(-2) ). For all 6 SNPs tested by meta-analysis (Pmeta ), the association with BD was strengthened, because the direction and magnitude of association were similar across populations (e.g., for rs7574070, odds ratio [OR] for A allele 1.29 [95% confidence interval (95% CI) 1.21-1.37], Pmeta  = 2.34 × 10(-16) ; for rs7616215, OR for C allele 0.70 [95% CI 0.65-0.76], Pmeta  = 1.54 × 10(-19) ; for rs17810546, OR for A allele 0.60 [95% CI 0.52-0.70], Pmeta  = 6.34 × 10(-11) ; for rs2617170, OR for T allele 0.76 [95% CI 0.70-0.81], Pmeta  = 2.75 × 10(-14) ; for rs13154629, OR for TT genotype 2.76 [95% CI 2.01-3.80], Pmeta  = 3.57 × 10(-10) ).
CONCLUSION: This study reinforces the notion that CCR1, KLRC4, IL12A-AS1, STAT4, and ERAP1 are bona fide susceptibility genes for BD, in addition to the MHC, IL10, and IL23R-IL12RB2 loci. Future genetic and functional studies are now warranted to uncover the roles of these genes in the pathogenesis of BD.
© 2015, American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26097239     DOI: 10.1002/art.39240

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  15 in total

1.  The Immunogenetics of Behcet's Disease.

Authors:  Mustafa Anıl Yılmaz; Ümit Türsen
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

2.  A single endoplasmic reticulum aminopeptidase-1 protein allotype is a strong risk factor for Behçet's disease in HLA-B*51 carriers.

Authors:  Masaki Takeuchi; Michael J Ombrello; Yohei Kirino; Burak Erer; Ilknur Tugal-Tutkun; Emire Seyahi; Yilmaz Özyazgan; Norman R Watts; Ahmet Gül; Daniel L Kastner; Elaine F Remmers
Journal:  Ann Rheum Dis       Date:  2016-05-23       Impact factor: 19.103

3.  Distribution of rs17482078 and rs27044 ERAP1 polymorphisms in a group of Italian Behçet's syndrome patients: a preliminary case-control study.

Authors:  Maria Carmela Padula; Pietro Leccese; Emanuela Pellizzieri; Angela Anna Padula; Michele Gilio; Teresa Carbone; Nancy Lascaro; Giuseppina Tramontano; Giuseppe Martelli; Salvatore D'Angelo
Journal:  Intern Emerg Med       Date:  2019-02-28       Impact factor: 3.397

4.  Variant in ERAP1 promoter region is associated with low expression in a patient with a Behçet-like MHC-I-opathy.

Authors:  Chrysoula Dimopoulou; Jens D Lundgren; Jon Sundal; Henrik Ullum; Pål Aukrust; Finn C Nielsen; Rasmus L Marvig
Journal:  J Hum Genet       Date:  2019-12-23       Impact factor: 3.172

Review 5.  Immune Regulatory Genes Are Major Genetic Factors to Behcet Disease: Systematic Review.

Authors:  Yan Deng; Weifeng Zhu; Xiaodong Zhou
Journal:  Open Rheumatol J       Date:  2018-06-29

6.  Epistatic Interaction of ERAP1 and HLA-B*51 in Iranian Patients with Behçet's Disease.

Authors:  Mahdi Mahmoudi; Amir Ashraf-Ganjouei; Ali Javinani; Farhad Shahram; Akira Meguro; Nobuhisa Mizuki; Nooshin Ahmadzadeh; Saeideh Jafarinejad-Farsangi; Shayan Mostafaei; Hoda Kavosi; Seyedeh Tahereh Faezi; Maassoumeh Akhlaghi; Fereydoun Davatchi
Journal:  Sci Rep       Date:  2018-12-04       Impact factor: 4.379

Review 7.  The role of polymorphic ERAP1 in autoinflammatory disease.

Authors:  Emma Reeves; Edward James
Journal:  Biosci Rep       Date:  2018-08-29       Impact factor: 3.840

8.  New Insights into Behçet's Syndrome Metabolic Reprogramming: Citrate Pathway Dysregulation.

Authors:  Anna Santarsiero; Pietro Leccese; Paolo Convertini; Angela Padula; Paolo Abriola; Salvatore D'Angelo; Faustino Bisaccia; Vittoria Infantino
Journal:  Mediators Inflamm       Date:  2018-06-28       Impact factor: 4.711

Review 9.  Behçet's Disease: An Overview of Etiopathogenesis.

Authors:  Pietro Leccese; Erkan Alpsoy
Journal:  Front Immunol       Date:  2019-05-10       Impact factor: 7.561

10.  Genome wide analysis for mouth ulcers identifies associations at immune regulatory loci.

Authors:  Tom Dudding; Simon Haworth; Penelope A Lind; J Fah Sathirapongsasuti; Joyce Y Tung; Ruth Mitchell; Lucía Colodro-Conde; Sarah E Medland; Scott Gordon; Benjamin Elsworth; Lavinia Paternoster; Paul W Franks; Steven J Thomas; Nicholas G Martin; Nicholas J Timpson
Journal:  Nat Commun       Date:  2019-03-05       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.